As a broad-spectrum antimicrobial
material, ZnO nanoparticles (NPs)
offer a novel approach to infected wounds in the clinic; however,
it is very necessary to improve the antimicrobial performance of ZnO
to satisfy the clinic requirements. In this work, a new antimicrobial
hybrid ZnO@PDA/GL13K was prepared by attaching the antimicrobial GL13K
peptide on the surface of ZnO NPs via polydopamine (PDA) as a covalent
bonding agent, which can enhance the reactive oxygen species (ROS)
production and damage the cell wall, showing superior antimicrobial
efficacy. Besides, the ZnO@PDA/GL13K hybrid can promote the healing
of bacterial infected wounds, with the wound area only remaining 1.8%
on day 9, about 2 times smaller than that of the ZnO group. Moreover,
ZnO@PDA/GL13K also showed good biocompatibility, and no side effect
on normal tissue and organs was found, implying that the antimicrobial
hybrid may possess prospective application in biomedical fields.